Canada markets close in 2 hours 22 minutes

NervGen Pharma Corp. (NGEN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
2.1700+0.1700 (+8.59%)
As of 01:37PM EDT. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
Operating Expenses
Research Development
14,066
16,613
6,872
6,163
Selling General and Administrative
6,272
6,338
5,938
5,031
Total Operating Expenses
20,388
23,025
12,811
11,196
Operating Income or Loss
-20,388
-23,025
-12,811
-11,196
Interest Expense
0
514.599
0
-
Total Other Income/Expenses Net
1,845
2,616
55.229
-9.109
Income Before Tax
-18,929
-20,722
-12,727
-11,186
Income from Continuing Operations
-18,929
-20,722
-12,727
-11,186
Net Income
-18,929
-20,722
-12,727
-11,186
Net Income available to common shareholders
-18,929
-20,722
-12,727
-11,186
Basic EPS
-0.33
-0.39
-0.32
-0.35
Diluted EPS
-0.33
-0.39
-0.32
-0.35
Basic Average Shares
59,091
52,649
39,289
32,112
Diluted Average Shares
59,091
52,649
39,289
32,112